A good night’s sleep is crucial to health and well-being.
Numerous research studies have shown that insomnia can increase the risk of cardiovascular events, obesity, diabetes and other illnesses.
In a study from Wake Forest University, scientists found strong improvements in not only sleep quality but also in improved autonomic nervous system function using a closed-loop, acoustic stimulation neurotechnology.
Cereset Research with Standard Operating Procedures (CR-SOP) is the evolution of HIRREM, or high-resolution, relational, resonance-based electroencephalic mirroring, a noninvasive, closed-loop technology that uses scalp sensors to monitor brainwaves and software algorithms to translate specific frequencies into audible tones of varying pitch.
These tones linked to brainwaves are echoed back in real time via earbuds. This allows the brain a chance to listen to itself, to look at itself in an acoustic mirror.
During the intervention, the brain continuously updates with respect to its own activity patterns, resulting in auto-calibration or self-optimization.
While still echoing brainwaves, as with legacy HIRREM, CR-SOP uses an updated platform with faster computers, new sensors and hardware, and computer management during the protocols.
This results in the faster echoing of brainwaves, shorter sessions and reduced dependence on technologist expertise.
In the study, the team tested 22 adults.
About half of the participants received 10 sessions of CR-SOP linked to brainwaves while the control group received 10 sessions of randomly generated auditory tones.
After completion of the sessions and at follow-up visits up to six weeks later, the team found the CR-SOP group reported fewer insomnia symptoms.
They also showed strong improvement in autonomic function across multiple measures such as heart rate variability compared to those who received random tones.
Heart rate variability is a powerful biometric that reflects the health of the autonomic nervous system, HRV is correlated with many important health and well-being outcomes.
The study also used standard operating procedures so that all people received the same sequence of protocols. Taken together, this greatly increases the scalability of this approach so that more people might have access, more quickly.
If you care about sleep, please read studies about drug that can treat sleep loss and insomnia, and how to deal with “COVID-somnia” and sleep well at night.
For more information about health, please see recent studies about a new drug that could prevent COVID-19, and results showing common sleep drugs may harm your cognitive functions.
The study was conducted by Charles H. Tegeler et al and published in Global Advances in Integrative Medicine and Health.
Copyright © 2023 Knowridge Science Report. All rights reserved.
